Impax Asset Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$10.2M Buy
150,700
+6,600
+5% +$479K 0.6% 81
2018
Q1
$11.1M Buy
+144,100
New +$10.7M 0.64% 75
2015
Q1
Sell
-210,299
Closed -$8.01M 206
2014
Q4
$8.01M Sell
210,299
-175
-0.1% -$6.4K 0.47% 59
2014
Q3
$7.47M Buy
210,474
+188
+0.1% +$6.99K 0.48% 62
2014
Q2
$8.22M Buy
210,286
+48,387
+30% +$1.81M 0.52% 60
2014
Q1
$5.9M Buy
161,899
+143,199
+766% +$5.22M 0.38% 67
2013
Q4
$647K Sell
18,700
-445,000
-96% -$14.3M 0.04% 165
2013
Q3
$13M Sell
463,700
-100,730
-18% -$2.69M 0.86% 49
2013
Q2
$15.2M Buy
+564,430
New +$15.6M 1.03% 40

Other funds holding XYL

Impax Asset Management's XYL Position: Q2 2018 in Review

Impax Asset Management increased its Xylem (XYL) stake by 4.6% in Q2 2018, buying an estimated $479K and bringing the position to 150,700 shares worth $10.2M. The position accounts for 0.6% of the portfolio, ranked #81.

Impax Asset Management first reported a position in XYL in Q2 2013 and has held it in 9 quarters since. The position peaked at $15.2M in Q2 2013. 645 funds tracked by Wall St. Rank hold XYL as of Q2 2018.

  • Impax Asset Management held 150,700 shares of Xylem worth $10.2M as of Q2 2018.
  • Impax Asset Management bought 6,600 Xylem shares in Q2 2018, an estimated $479K.
  • Xylem made up 0.6% of Impax Asset Management's portfolio in Q2 2018, its #81 holding.
  • Impax Asset Management first reported a position in Xylem in Q2 2013 and has held it in 9 quarters since.
  • Impax Asset Management's Xylem position peaked at $15.2M in Q2 2013.
  • 645 funds tracked by Wall St. Rank held Xylem as of Q2 2018.

Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.